Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690
Clinical trial NCT04046250 · COMPLETED
Trial details
- NCT number
- NCT04046250
- Sponsor
- Tosk, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2019-10-10
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.